ReviewFrontiers in bioengineering and biotechnology2025
Metal-organic frameworks-loaded indocyanine green for enhanced phototherapy: a comprehensive review.
Review in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nanomaterial-Based Photothermal Therapy for Inflammatory Diseases: Intervention Strategies, Synergistic Effects, and Future Challenges.International journal of nanomedicine · 2026Review
- Targeted photodynamic therapy: enhancing efficacy through specific organelle engagement.Frontiers in pharmacology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Indocyanine green (ICG) is a small molecule approved by the U.S. Food and Drug Administration (FDA) for liver function imaging and angiography. ICG can be used not only for near-infrared imaging but also for photodynamic and photothermal therapy. However, the hydrophilicity of ICG leads to a relatively short blood circulation time, and it is easily cleared by organs such as the liver. Moreover, it lacks the targeting ability to the diseased sites. By using the natural porous metal-organic frameworks (MOFs) as the carrier, high-efficiency loading of ICG molecule can be achieved, which has significantly broadened its biomedical applications. This review comprehensively summarizes the research work in recent years regarding the utilization of MOF as a carrier to load ICG in the bioapplication such as malignant cancer inhibition, antibacterial treatment, and the treatment of Alzheimer's disease. It focuses on summarizing the design concepts of different types of MOF carriers for loading ICG molecules. Meanwhile, it emphasizes the enhanced therapeutic effects achieved when multiple treatment modalities realized through post-modification are combined with ICG-mediated phototherapy. It is expected that through the summary of this review, the biomedical applications of ICG in the field of disease treatment can be further promoted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.